Literature DB >> 22164127

AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.

Christoph Thomssen1, Anton Scharl, Nadia Harbeck.   

Abstract

Entities:  

Year:  2011        PMID： 22164127      PMCID： PMC3225216          DOI： 10.1159/000331459

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  215 in total

1.  Oral contraceptives and the risk of breast cancer.

Authors:  Polly A Marchbanks; Jill A McDonald; Hoyt G Wilson; Suzanne G Folger; Michele G Mandel; Janet R Daling; Leslie Bernstein; Kathleen E Malone; Giske Ursin; Brian L Strom; Sandra A Norman; Phyllis A Wingo; Ronald T Burkman; Jesse A Berlin; Michael S Simon; Robert Spirtas; Linda K Weiss
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

Review 2.  What is the evidence for the use of mindfulness-based interventions in cancer care? A review.

Authors:  Christina Shennan; Sheila Payne; Deborah Fenlon
Journal:  Psychooncology       Date:  2010-08-04       Impact factor: 3.894

3.  Vitamin D-effective solar UV radiation, dietary vitamin D and breast cancer risk.

Authors:  Kåre Edvardsen; Marit B Veierød; Magritt Brustad; Tonje Braaten; Ola Engelsen; Eiliv Lund
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

4.  Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.

Authors:  José Baselga; Karen A Gelmon; Shailendra Verma; Andrew Wardley; Pierfranco Conte; David Miles; Giulia Bianchi; Javier Cortes; Virginia A McNally; Graham A Ross; Pierre Fumoleau; Luca Gianni
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

5.  Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.

Authors:  Tomasz Byrski; Jacek Gronwald; Tomasz Huzarski; Ewa Grzybowska; Magdalena Budryk; Malgorzata Stawicka; Tomasz Mierzwa; Marek Szwiec; Rafal Wisniowski; Monika Siolek; Rebecca Dent; Jan Lubinski; Steven Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

6.  A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting.

Authors:  Tong J Gan; Kui Ran Jiao; Michael Zenn; Gregory Georgiade
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

7.  Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy.

Authors:  Robert C Kane; W David McGuinn; Ramzi Dagher; Robert Justice; Richard Pazdur
Journal:  Oncologist       Date:  2008-04

8.  Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.

Authors:  Vanessa Dumeaux; Elin Alsaker; Eiliv Lund
Journal:  Int J Cancer       Date:  2003-07-20       Impact factor: 7.396

Review 9.  Behavioral symptoms in patients with breast cancer and survivors.

Authors:  Julienne E Bower
Journal:  J Clin Oncol       Date:  2008-02-10       Impact factor: 44.544

10.  Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial.

Authors:  Ivana Sestak; Wolfgang Distler; John F Forbes; Mitch Dowsett; Anthony Howell; Jack Cuzick
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544
View more
  1 in total

1.  Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.

Authors:  Stephan Bartels; Matthias Christgen; Angelina Luft; Sascha Persing; Kai Jödecke; Ulrich Lehmann; Hans Kreipe
Journal:  Mod Pathol       Date:  2017-08-11       Impact factor: 7.842
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.